SMARCD1 and breast cancer: We previously reported that miR‐99a‐5p induces cellular senescence in gemcitabine‐resistant BC cells by targeting SMARCD1 [18], and that miRNA‐486‐5p overcomes the resistance of cisplatin‐resistant BC cells by targeting EHHADH [19].